These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23870627)

  • 1. A randomized trial of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated malaria among children in western Kenya.
    Agarwal A; McMorrow M; Onyango P; Otieno K; Odero C; Williamson J; Kariuki S; Kachur SP; Slutsker L; Desai M
    Malar J; 2013 Jul; 12():254. PubMed ID: 23870627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria among Children in Western Kenya, 2016 to 2017.
    Westercamp N; Owidhi M; Otieno K; Chebore W; Buff AM; Desai M; Kariuki S; Samuels AM
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0020722. PubMed ID: 36036611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre study.
    Ogutu BR; Onyango KO; Koskei N; Omondi EK; Ongecha JM; Otieno GA; Obonyo C; Otieno L; Eyase F; Johnson JD; Omollo R; Perkins DJ; Akhwale W; Juma E
    Malar J; 2014 Jan; 13():33. PubMed ID: 24472156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua New Guinea.
    Tavul L; Hetzel MW; Teliki A; Walsh D; Kiniboro B; Rare L; Pulford J; Siba PM; Karl S; Makita L; Robinson L; Kattenberg JH; Laman M; Oswyn G; Mueller I
    Malar J; 2018 Oct; 17(1):350. PubMed ID: 30290825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of dihydroartemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali.
    Dama S; Niangaly H; Djimde M; Sagara I; Guindo CO; Zeguime A; Dara A; Djimde AA; Doumbo OK
    Malar J; 2018 Oct; 17(1):347. PubMed ID: 30290808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the efficacy and safety of three 2-drug combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Senegal: artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine].
    Sow D; Ndiaye JL; Sylla K; Ba MS; Tine RC; Faye B; Pene M; Ndiaye M; Seck A; Lo AC; Abiola A; Dieng Y; Gaye O
    Med Sante Trop; 2016; 26(1):45-50. PubMed ID: 26644184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children.
    Arinaitwe E; Sandison TG; Wanzira H; Kakuru A; Homsy J; Kalamya J; Kamya MR; Vora N; Greenhouse B; Rosenthal PJ; Tappero J; Dorsey G
    Clin Infect Dis; 2009 Dec; 49(11):1629-37. PubMed ID: 19877969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Uncomplicated Plasmodium falciparum Malaria in Children Aged Less than 15 Years in Guinea-Bissau - An Open-Label Non-Inferiority Randomised Clinical Trial.
    Ursing J; Rombo L; Rodrigues A; Kofoed PE
    PLoS One; 2016; 11(9):e0161495. PubMed ID: 27649561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Hainan, China].
    Wang SQ; Christophel E; Lin SG; Meng F; Hu XM; Wang GZ; Liu J; Zeng LH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Feb; 26(1):50-2. PubMed ID: 18637586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uíge Provinces, angola.
    Plucinski MM; Talundzic E; Morton L; Dimbu PR; Macaia AP; Fortes F; Goldman I; Lucchi N; Stennies G; MacArthur JR; Udhayakumar V
    Antimicrob Agents Chemother; 2015 Jan; 59(1):437-43. PubMed ID: 25367912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya.
    Mens PF; Sawa P; van Amsterdam SM; Versteeg I; Omar SA; Schallig HD; Kager PA
    Malar J; 2008 Nov; 7():237. PubMed ID: 19017387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya.
    Juma EA; Obonyo CO; Akhwale WS; Ogutu BR
    Malar J; 2008 Dec; 7():262. PubMed ID: 19102746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized non-inferiority and safety trial of dihydroartemisin-piperaquine and artesunate-amodiaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroonian children.
    Nji AM; Ali IM; Moyeh MN; Ngongang EO; Ekollo AM; Chedjou JP; Ndikum VN; Evehe MS; Froeschl G; Heumann C; Mansmann U; Ogundahunsi O; Mbacham WF
    Malar J; 2015 Jan; 14():27. PubMed ID: 25626448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children.
    Nambozi M; Van Geertruyden JP; Hachizovu S; Chaponda M; Mukwamataba D; Mulenga M; Ubben D; D'Alessandro U
    Malar J; 2011 Feb; 10():50. PubMed ID: 21352609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015.
    Plucinski MM; Dimbu PR; Macaia AP; Ferreira CM; Samutondo C; Quivinja J; Afonso M; Kiniffo R; Mbounga E; Kelley JS; Patel DS; He Y; Talundzic E; Garrett DO; Halsey ES; Udhayakumar V; Ringwald P; Fortes F
    Malar J; 2017 Feb; 16(1):62. PubMed ID: 28153004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa.
    Yavo W; Faye B; Kuete T; Djohan V; Oga SA; Kassi RR; Diatta M; Ama MV; Tine R; Ndiaye JL; Evi JB; Same-Ekobo A; Faye O; Koné M
    Malar J; 2011 Jul; 10():198. PubMed ID: 21774826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gametocyte clearance in children, from western Kenya, with uncomplicated Plasmodium falciparum malaria after artemether-lumefantrine or dihydroartemisinin-piperaquine treatment.
    Omondi P; Burugu M; Matoke-Muhia D; Too E; Nambati EA; Chege W; Musyoka KB; Thiongo K; Otinga M; Muregi F; Kimani F
    Malar J; 2019 Dec; 18(1):398. PubMed ID: 31801562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria.
    Zani B; Gathu M; Donegan S; Olliaro PL; Sinclair D
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD010927. PubMed ID: 24443033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda.
    Yeka A; Dorsey G; Kamya MR; Talisuna A; Lugemwa M; Rwakimari JB; Staedke SG; Rosenthal PJ; Wabwire-Mangen F; Bukirwa H
    PLoS One; 2008 Jun; 3(6):e2390. PubMed ID: 18545692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.